Virus-Like Particle Traps for Small Molecule-Protein Interaction Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting protein-protein and small molecule-protein interactions face challenges such as non-physiological conditions, false positives, limited sensitivity, and inability to identify weak interactions, particularly in genetic systems and biochemical co-purification strategies.
Innovation Solution
The use of artificial virus-like particles (VLPs) to trap small molecule-protein complexes under physiological conditions, allowing for the isolation and identification of small molecule-protein interactions through mild enrichment and mass spectrometry analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If genetic interaction detection methods (yeast two-hybrid, phage display, Mappit system) are used to detect protein-protein interactions, then interaction detection capability is improved, but false positive signals increase due to overexpression of interaction partners and non-physiological conditions
Solution Approach 1:
The invention changes the concentration parameter of interaction partners from overexpressed (genetic methods) to endogenous physiological levels. By using endogenous proteins without overexpression, the system maintains physiological relevance and reduces false positives while preserving interaction detection capability.
Solution Approach 2:
The invention creates a physiological environment by performing interactions in living cells under native conditions, protecting the interaction complex from non-physiological factors present in traditional biochemical assays. This inert physiological environment maintains reliability while enabling detection.
2Manufacturing precision
If biochemical co-purification strategies are used with detergent-based lysis and extensive washing, then purification is improved, but loss of interaction factors occurs leading to false negatives
Solution Approach 1:
The invention performs the interaction trapping action before cell lysis occurs. By capturing the interaction complex in situ within living cells using VLPs, the system preserves weak and transient interactions that would otherwise be lost during detergent-based lysis and washing procedures.
Solution Approach 2:
The invention introduces virus-like particles as an intermediary carrier that selectively captures and protects the interaction complex. The VLPs act as a protective intermediary that maintains complex integrity during purification, preventing loss of interaction factors while enabling high-quality purification.
3Measurement precision
If extensive washing steps are performed during co-purification to compensate for MS instrument sensitivity, then measurement sensitivity is improved, but loss of cellular integrity occurs causing false positives
Solution Approach 1:
The invention performs interaction trapping in situ before cell lysis, capturing complexes under intact cellular conditions. This preliminary capture preserves cellular integrity and prevents spurious interactions, while the subsequent mild purification maintains sufficient complex integrity for MS detection without requiring extensive washing.
4Productivity
If phage display methodology is used to screen protein interactions, then interaction screening capability is improved, but physiological relevance deteriorates due to non-physiological environment exposure
Solution Approach 1:
The invention changes the environmental parameter from non-physiological (phage surface exposure) to physiological (intracellular conditions). By performing interactions inside living cells at physiological temperature, pH, and ionic strength, the system maintains physiological relevance while enabling comprehensive screening.
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
The present invention relates to a virus-like particle, in which a small molecule-protein complex is entrapped, ensuring the formation of the small molecule-protein complex under physiological conditions, while protecting said small molecule-protein complex during purification and identification. The invention relates further to the use of such virus like particle for the isolation and identification of small molecule-protein complexes.